CORC

在结果中检索

CORC

浏览/检索结果: 共91条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Quantitation of serum pregnanediol-3-glucuronide level in different endocrine statuses by LC-MS/MS 期刊论文
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 卷号: 184
作者:  Chen, Jian;  Hou, Hongwei;  Chen, Huan;  Luo, Yanbo;  He, Yunlu
收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26
Application of a novel gene encoding bromophenol dehalogenase from Ochrobactrum sp. T in TBBPA degradation 期刊论文
CHEMOSPHERE, 2019, 卷号: 217, 页码: 507-515
作者:  Liang, Zhishu;  Li, Guiying;  Mai, Bixian;  Ma, Huimin;  An, Taicheng
收藏  |  浏览/下载：4/0  |  提交时间：2020/04/27
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：57/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Identification of a Single Nucleotide Polymorphism in NFKBIA with Different Effects on Psoriatic Arthritis and Cutaneous Psoriasis in China 期刊论文
ACTA DERMATO-VENEREOLOGICA, 2019, 卷号: 99, 期号: 1, 页码: 84-88
作者:  Zhao, Qing;  Sun, Yonghu;  Fu, Xi'an;  Wang, Zhenzhen;  Yu, Gongqi
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/11
State-of-the-Art Internet of Things in Protected Agriculture 期刊论文
SENSORS, 2019, 卷号: 19, 期号: 8
作者:  Shi, Xiaojie;  An, Xingshuang;  Zhao, Qingxue;  Liu, Huimin;  Xia, Lianming
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace